JACQUELINE SALAS-SPIEGEL, MD: This class really addresses the basic problem that's going on in diabetes, which is insulin resistance. So what we're trying to do is to make the body more sensitive to insulin, less resistant to insulin and this class of drugs can really address that problem at the levels where the resistance takes place.
ASTRID ALMODOVAR, MD: The second class of medications, they've been in use for a long, long time, and they work by stimulating the pancreas to produce more insulin.
ANNOUNCER: There is also a new but similar group of drugs that also cause the pancreas to release insulin, but they do so very quickly, so they are taken at mealtime.
ASTRID ALMODOVAR, MD: Other medications that we use early on are the ones that are used to delay the absorption of carbohydrates.
ANNOUNCER: Delaying the absorption of carbohydrates gives the body's natural insulin production a better chance to keep blood glucose levels close to normal.
JACQUELINE SALAS-SPIEGEL, MD: If patients with Type 2 haven't achieved their blood sugar goal with a variety of oral treatments along with diet and exercise, the next step in their treatment is definitely insulin.
ASTRID ALMODOVAR, MD: The beauty of treating diabetes is that we can prevent the complications that I said, and this is not unavoidable. We know that with proper care and management of all the risk factors they can prevent, we can reverse and prevent the cardiovascular complications.
JACQUELINE SALAS-SPIEGEL, MD: The good news about Type 2 diabetes is that, with the current treatment modalities available to us today, which were certainly not available ten years ago, most, if not all, patients with Type 2 diabetes can be well-controlled.